Business Wire

Horizon Therapeutics plc to Host Virtual R&D Day on Sept. 29, 2021

DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it will host a virtual R&D Day for investors and analysts on Wednesday, Sept. 29, 2021 at 8 a.m. CT. Horizon’s R&D Day will include presentations from the Company’s R&D leadership team and key opinion leaders with a focus on the Company’s pipeline.

Additional details, including how to access the live webcast, will follow closer to the event. A recorded archived version of the webcast will be available on Horizon’s website shortly after the event.

About Horizon

Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, please visit and follow us on Twitter, LinkedIn, Instagram and Facebook.


Tina Ventura
Senior Vice President, Investor Relations

Ruth Venning
Executive Director, Investor Relations

U.S. Media:
Geoff Curtis
Executive Vice President, Corporate Affairs & Chief Communications Officer

Ireland Media:
Ray Gordon
Gordon MRM



Subscribe to the BAM Newsletter

Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.